Importantly, Yoda1, a previously identified Piezo1 chemical activator 31, restored the decreased intracellular Ca2+ concentration and the reduced apoptotic rate of MSCs under MG conditions. This evidence concerns the gene PIEZO1 and myasthenia gravis.